CasNo.121809-54-9,2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID,2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID(121809-54-9) Suppliers

0	Negotiable

Min.Order :0
Purity: ≥99%

Keywords

2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID;2-[4-(AMINOCARBONYL)PHENOXY]-2-METHYLPROPANOIC ACID high quality 2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID supplier manufacturer high purity 121809-54-9

Quick Details

Appearance:detailed see specifications
Application:Pharmaceutical intermediates.etc
PackAge:according to customer's requirement
ProductionCapacity:
Storage:Store in cool & dry place
Transportation:as per your request

Superiority:

1. Production capacity: we have three production base with high-tech production equipment and instruments, equipped with professional production personnel, meet your requirements.
2. Quality assurance: we have a first-class testing equipment and testing personnel, in strict accordance with ISO and cGMP standards, ensure that the quality of the shipment.
3.Ultra-low prices, we follow the meager profit but high turnover principle to win more customers, to provide you with quality and cheap products.
4.The best service: we can real-time quotation, tracking service, ensure the safety of the goods to the clients.
5. Customer groups: our clients throughout the world more than 30 countries, high quality products, low price, best service to win the customer's consistent high praise.
If you demand the product, you are welcome to contact us at any time, we guarantee that you seriously every inquiry, give you the fastest reply and the best service.

Details:

2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID Basic information
Product Name:2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID
Synonyms:2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID;2-[4-(AMINOCARBONYL)PHENOXY]-2-METHYLPROPANOIC ACID
CAS:121809-54-9
MF:C11H13NO4
MW:223.23
EINECS:
Product Categories:
Mol File:121809-54-9.mol
2-(4-CARBAMOYLPHENOXY)-2-METHYLPROPIONIC ACID Chemical Properties
Safety Information
Hazard Codes Xn
Risk Statements 22-36
Safety Statements 26